Search - tctmd.com

Displaying 1 - 20 of 324

Sort: Relevancy | Date

Presentation TVT 2016

Real-World Applications of Transcatheter LAA Closure: Defining the Indications and Techniques

Presenter: Saibal Kar

June 18, 2016

Presentation TVT 2016

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

Presenter: Fabian Nietlispach

June 17, 2016

Presentation TVT 2016

Concomitant (or Sequential) Procedures During Transcatheter Mitral Repair: Time to Consider LAA Closure?

Presenter: Fabian Nietlispach

June 16, 2016

Presentation SOLACI 2016

Contemporaneous Approach of The Left Atrial Appendage and Patent Oval Foramen: When Intervention is Indicated

Presenter: Carlos AC Pedra

June 09, 2016

Presentation EuroPCR 2016

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

May 20, 2016

Presentation EuroPCR 2016

EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe

Presenter: Martin Bergmann

May 18, 2016

Presentation Fellows 2016

Good Transseptal Technique and the Procedures You Can Do With It (LAA, Mitral, and Beyond)

Presenter: Mark Reisman

April 17, 2016

Presentation ECHO 2016

Live Dissection of the heart

Presenter: Madalina Petrescu

March 23, 2016

Presentation ECHO 2016

Clinical Decision Making: Stroke and Structural Interventions

Presenter: Robert J. Sommer

March 23, 2016

Presentation JIM 2016

The Italian Experience with the Amplatzer Technology

Presenter: Jacopo A Oreglia

February 10, 2016

Presentation Scripps 2016

Putting It All Together: Warfarin, NOAC or LAA Closure?

Presenter: Brian K. Whisenant

February 04, 2016

Presentation Scripps 2016

LAA Closure Fundamentals: Keys to a Successful Procedure

Presenter: Matthew J. Price

February 04, 2016

Presentation Scripps 2016

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

Presenter: Brian Whisenant

February 04, 2016

Presentation Scripps 2016

LAA Closure for Stroke Prevention: Rationale and Identifying the Patient Who Might Benefit

Presenter: Brian K. Whisenant

February 03, 2016

Presentation Scripps 2016

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

Presenter: Brian K. Whisenant

February 03, 2016

Presentation

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presenter: Vivek Y. Reddy

December 13, 2015

Presentation

Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-term Warfarin

Presenter: Matthew J. Price

November 29, 2015

Presentation

LAA Exclusion (Anatomy & Imaging)

Presenter: Luis Miguel Ben?tez G?mez

October 30, 2015

Presentation

Imaging Techniques for the Guidance of Left Atrial Intervention

Presenter: Brij Miani

October 29, 2015

Presentation

LAA Closure: First in Man With the Fourth-Generation Watchman Device

Presenter: J. Ledwoch

September 15, 2015

Advertisement

Real-World Applications of Transcatheter LAA Closure: Defining the Indications and Techniques

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

Concomitant (or Sequential) Procedures During Transcatheter Mitral Repair: Time to Consider LAA Closure?

Contemporaneous Approach of The Left Atrial Appendage and Patent Oval Foramen: When Intervention is Indicated

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe

Good Transseptal Technique and the Procedures You Can Do With It (LAA, Mitral, and Beyond)

Live Dissection of the heart

Clinical Decision Making: Stroke and Structural Interventions

The Italian Experience with the Amplatzer Technology

Putting It All Together: Warfarin, NOAC or LAA Closure?

LAA Closure Fundamentals: Keys to a Successful Procedure

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

LAA Closure for Stroke Prevention: Rationale and Identifying the Patient Who Might Benefit

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-term Warfarin

LAA Exclusion (Anatomy & Imaging)

Imaging Techniques for the Guidance of Left Atrial Intervention

LAA Closure: First in Man With the Fourth-Generation Watchman Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content